Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
about
Erythrocytes as Potential Link between Diabetes and Alzheimer's DiseaseAlzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.
P2860
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
@en
type
label
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
@en
prefLabel
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
@en
P2093
P2860
P50
P1433
P1476
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.
@en
P2093
Bethany Ball
Candice ManYan
Kathryn Goozee
Kevin Taddei
Manohar L Garg
Preeti Dave
P2860
P2888
P356
10.1038/S41598-017-00751-2
P407
P577
2017-04-06T00:00:00Z
P6179
1084130851